Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Apr;25(4):606-609.e1.
doi: 10.1016/j.jamda.2023.07.005. Epub 2023 Aug 10.

Agreement of Antipsychotic Use between Nursing Home Electronic Records and Minimum Data Set

Affiliations
Randomized Controlled Trial

Agreement of Antipsychotic Use between Nursing Home Electronic Records and Minimum Data Set

Tingting Zhang et al. J Am Med Dir Assoc. 2024 Apr.

Abstract

Objectives: Nursing home (NH) Minimum Data Set (MDS) have frequently been used to measure medication use in epidemiologic studies, but there is little evidence on the accuracy of MDS-based medication records. We compared antipsychotic use estimated using 2 data sources-MDS and NH electronic medication administration records (eMAR).

Design: Cross-sectional comparison.

Setting and participants: This analysis was based on MDS and linked eMAR data of 604 NH residents with dementia at 54 NHs in 10 states, participating in a cluster-randomized pragmatic trial (METRIcAL), from June 2019 to February 2020.

Methods: One admission, quarterly, or annual MDS assessment was chosen for each participant. The MDS assessment recorded the number of antipsychotic treatment days during a 7-day window. We then identified antipsychotic administrations during the corresponding window in the eMAR. We used Cohen kappa to assess agreement in the proportion of participants on antipsychotics during the week and used intraclass correlation coefficient (ICC) to assess the agreement of treatment days. We further used the eMAR data as a reference to calculate validity parameters.

Results: A total of 29.5% of study participants were identified as antipsychotic users based on the MDS vs 28.3% based on the eMAR data (kappa value: 0.96). MDS-based average treatment duration was estimated to be 2.0, consistent with eMAR-based estimate (1.8 days, ICC: 0.96). The sensitivity was 98.8% (95% CI 95.8%-99.9%), the specificity was 97.9% (95% CI 96.1%-99.1%), the positive predictive value was 94.9% (95% CI 90.8%-97.3%), and the negative predictive value was 99.5% (95% CI 98.2%-99.9%).

Conclusions and implications: Agreement between the MDS and eMAR in antipsychotic use is high, suggesting that the MDS is a valid tool to measure antipsychotic use in epidemiologic studies. Further studies with large and diverse populations are warranted to confirm our findings.

Keywords: Nursing home; antipsychotics; electronic health records; minimum data set.

PubMed Disclaimer

Conflict of interest statement

Disclosure: All co-authors report no conflicts of interest.

References

    1. Baier RR, Jump RLP, Zhang T, Kabbani S, Gifford DR, Gravenstein S. Feasibility of a Nursing Home Antibiotic Stewardship Intervention. J Am Med Dir Assoc. Jun 2022;23(6):1025–1030. doi:10.1016/j.jamda.2021.08.019 - DOI - PMC - PubMed
    1. Davidson HEJ, R.L.P. Challenges in Tracking and Reporting Antibiotic Use in Long-Term Care. Journal of the American Medical Directors Association. 2020;21(9) - PubMed
    1. Owen RR, Thrush CR, Cannon D, et al. Use of electronic medical record data for quality improvement in schizophrenia treatment. J Am Med Inform Assoc. Sep-Oct 2004;11(5):351–7. doi:10.1197/jamia.M1498 - DOI - PMC - PubMed
    1. Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist. Jun 1990;30(3):293–307. doi:10.1093/geront/30.3.293 - DOI - PubMed
    1. Gerlach LB, Park PS, Shireman TI, Bynum JPW. Changes in medication use among long-stay residents with dementia in Michigan during the pandemic. J Am Geriatr Soc. Jul 2021;69(7):1743–1745. doi:10.1111/jgs.17161 - DOI - PMC - PubMed

Publication types

Substances